- Home
- TOMZ vs PMN Comparison
TOMZ vs PMN Comparison
Compare TOMZ & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- PMN
- Stock Information
- Founded
- TOMZ 1979
- PMN 2004
- Country
- TOMZ United States
- PMN Canada
- Employees
- TOMZ N/A
- PMN N/A
- Industry
- TOMZ Diversified Commercial Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- TOMZ Finance
- PMN Health Care
- Exchange
- TOMZ Nasdaq
- PMN Nasdaq
- Market Cap
- TOMZ 15.7M
- PMN 18.8M
- IPO Year
- TOMZ N/A
- PMN N/A
- Fundamental
- Price
- TOMZ $0.84
- PMN $0.50
- Analyst Decision
- TOMZ Strong Buy
- PMN Strong Buy
- Analyst Count
- TOMZ 1
- PMN 1
- Target Price
- TOMZ $3.50
- PMN $6.00
- AVG Volume (30 Days)
- TOMZ 16.0K
- PMN 39.5K
- Earning Date
- TOMZ 05-08-2025
- PMN 05-20-2025
- Dividend Yield
- TOMZ N/A
- PMN N/A
- EPS Growth
- TOMZ N/A
- PMN N/A
- EPS
- TOMZ N/A
- PMN 0.11
- Revenue
- TOMZ $7,738,842.00
- PMN N/A
- Revenue This Year
- TOMZ $9.68
- PMN N/A
- Revenue Next Year
- TOMZ $130.22
- PMN N/A
- P/E Ratio
- TOMZ N/A
- PMN $4.86
- Revenue Growth
- TOMZ 5.22
- PMN N/A
- 52 Week Low
- TOMZ $0.60
- PMN $0.51
- 52 Week High
- TOMZ $1.50
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- TOMZ 57.28
- PMN 35.49
- Support Level
- TOMZ $0.79
- PMN $0.59
- Resistance Level
- TOMZ $0.87
- PMN $0.72
- Average True Range (ATR)
- TOMZ 0.04
- PMN 0.07
- MACD
- TOMZ 0.01
- PMN -0.00
- Stochastic Oscillator
- TOMZ 80.69
- PMN 11.93
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.